India Reduces Prices of 120 Cancer Medicines as 70 Pharma Companies Submit Revised Rates
The National Pharmaceutical Pricing Authority estimates that the revised medicine prices could generate savings of approximately ₹3,357.49 crore for patients and the healthcare system. The estimate was calculated by comparing the previous and revised maximum retail prices and applying the difference to sales volumes recorded between April 2025 and March 2026.